MediCore AI: Singapore's Medical Imaging Revolution with AI

Date: March 2026

Singapore's healthcare system has long been celebrated for its efficiency and quality, but even the best radiologists face a growing challenge: the sheer volume of medical images that need to be analyzed. Enter MediCore AI, a Singapore-based AI startup that's transforming how doctors interpret X-rays, CT scans, and MRIs—potentially catching life-threatening conditions earlier than ever before.

The Challenge: Radiologists Under Pressure

Medical imaging is the backbone of modern diagnostics, but the demand for scans has outpaced the supply of trained radiologists worldwide. In Singapore's public hospitals, a single radiologist may be asked to review hundreds of images daily, increasing the risk of missed findings or delayed diagnoses.

"Every minute counts when you're looking at a potential tumor or internal bleeding," explained Dr. Amanda Lee, Chief Medical Officer at MediCore AI and a former radiologist at Singapore General Hospital. "We're not replacing doctors—we're giving them a second set of eyes that never gets tired and can flag potential issues in seconds."

How MediCore AI Works: Intelligent Image Analysis

MediCore AI's flagship product, ScanSentry, uses deep learning models trained on millions of annotated medical images from hospitals across Singapore, Southeast Asia, and beyond. The system integrates seamlessly with existing hospital picture archiving and communication systems (PACS), automatically analyzing each new scan as it enters the queue.

What makes ScanSentry particularly powerful is its multi-modal analysis capability. Unlike earlier AI systems that focus on a single imaging modality, MediCore AI's models can simultaneously analyze X-rays, CT scans, MRIs, and even ultrasound images—providing a comprehensive assessment that would take human radiologists much longer to achieve.

The AI doesn't just look for obvious abnormalities. It uses probabilistic reasoning to identify subtle patterns that might indicate early-stage disease, assigning each finding a confidence score that helps radiologists prioritize their review.

Real-World Impact: Catching What Others Miss

MediCore AI is already making a difference in Singapore's hospitals. Since partnering with the National University Hospital (NUH) in late 2025, ScanSentry has analyzed over 50,000 chest X-rays, flagging more than 200 cases where potential lung nodules were identified for further review.

One notable case involved a routine X-ray for a patient admitted for a minor injury. ScanSentry detected a subtle shadow in the upper right lung that the reviewing radiologist initially missed due to the image quality. A follow-up CT scan confirmed an early-stage lung cancer, and the patient was able to receive treatment before the disease progressed.

"That patient is alive today because our AI caught something that could easily have been overlooked," said Dr. Lee. "That's the power of augmented intelligence in healthcare."

Singapore's Hub for HealthTech Innovation

MediCore AI's success reflects Singapore's growing position as a hub for health technology innovation. The company was founded in 2024 by a team of AI researchers from the National University of Singapore (NUS) and clinicians from Singapore's public healthcare system, combining deep technical expertise with real-world medical insight.

The startup has raised S$8 million in seed funding from a consortium including Sequoia Capital's Southeast Asia fund, HealthXCapital, and the SingaporeMed Tech Fund. The capital is being used to expand the company's training dataset and obtain regulatory approval for deployment in additional markets.

"Singapore offers the perfect ecosystem for health AI companies," said James Chen, MediCore AI's co-founder and CEO. "We have access to high-quality medical data, world-class hospitals for clinical validation, and a regulatory framework that supports innovation while ensuring patient safety."

Regulatory Approval and Expansion Plans

In February 2026, MediCore AI received Class B medical device certification from the Health Sciences Authority (HSA), clearing the way for broader deployment in Singapore's public and private healthcare institutions. The company is now in discussions with hospitals in Malaysia, Thailand, and Indonesia to bring ScanSentry to Southeast Asia.

The company is also expanding its AI capabilities beyond diagnostic imaging. A new partnership with the Duke-NUS Medical School is developing AI models for predicting patient deterioration based on continuous vital sign monitoring—a potentially life-saving tool for ICUs.

The Future of AI in Healthcare

Looking ahead, MediCore AI envisions a future where AI-assisted diagnostics become the standard of care worldwide. The company is currently developing models for detecting early signs of diabetic retinopathy from retinal scans, predicting cardiovascular risk from cardiac CT images, and identifying neurological conditions from brain MRI scans.

"Our goal is to make world-class diagnostic capabilities accessible to every hospital and clinic, regardless of location," said Chen. "We believe AI should augment the expertise of doctors, not replace them—and that's exactly what we're building."

For Singapore's healthcare system, MediCore AI represents a new chapter in the city-state's evolution into a global medical technology powerhouse. By combining cutting-edge AI with rigorous clinical validation, the startup is demonstrating that Singapore's innovation ecosystem can produce solutions with real-world impact on human lives.

This article is part of our ongoing coverage of Singapore's AI ecosystem. For more AI news and insights from the Lion City, stay tuned to AI Dominance SG.

Related Resources

Learn more about Singapore's AI initiatives at AI Supremacy Singapore, your comprehensive resource for AI developments in the Lion City.

Explore the latest in Singapore technology and innovation coverage at AI Dominance SG.